Fate Therapeutics Inc
FATE
$2.13-2.29%
End of day · as of Oct 13, 2026, 2:15 AM ET
Mkt cap
$331.03M
EV/Sales
42.8
P/E ratio
N/A
FY2025 Revenue
$6.65M
EPS (TTM)
$-1.05
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-2051.08%
Beta
2.14
Div yield
N/A
Sector
Healthcare
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Latest reported FATE revenue for 2025-12-31 was $6.6M. Net income was -$136.3M. Revenue was down 51.2% from 2024-12-31 to 2025-12-31. FATE currently screens at market cap $331.0M.
Use this FATE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full FATE income, balance, and cash tables.
Fate Therapeutics Inc (FATE) is a biotechnology company in the Healthcare sector.
Latest cached Fate Therapeutics Inc (FATE) revenue for Dec 31, 2025 was $6.6M. Net income was -$136.3M. Statements: https://lician.com/financials/fate
Fate Therapeutics Inc (FATE) market capitalization is $331.0M on the latest cached snapshot.
Fate Therapeutics Inc (FATE) cached previous close $2.18; day range $2.13 – $2.14; volume 545,982. Session quote: https://lician.com/quote/fate
Fate Therapeutics Inc (FATE) latest cached earnings event is "FATE earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached FATE filing is 8-K · Sep 28, 2026. Filings: https://lician.com/sec/fate